We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $1.68B
1-Year Est. Return 373.57%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+373.57%
3 Year Est. Return
+2,009.68%
5 Year Est. Return
+1,118.82%
10 Year Est. Return
+17,700.84%
AUM
$316M
AUM Growth
+$75.1M
Cap. Flow
-$37.2M
Cap. Flow %
-11.79%
Top 10 Hldgs %
72.69%
Holding
66
New
18
Increased
6
Reduced
8
Closed
20

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.49%
2 Materials 9.89%
3 Consumer Discretionary 9.4%
4 Financials 7.66%
5 Energy 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$951B
$1.58M 0.5%
17,280
-12,720
-42% -$1.1M
IRD
27
Opus Genetics
IRD
$307M
$1.5M 0.47%
+10,901
New +$2.12M
SHIPW
28
DELISTED
Seanergy Maritime Holdings Corp Class A Warrants
SHIPW
$1.49M 0.47%
1,432,500
CEF icon
29
Sprott Physical Gold and Silver Trust
CEF
$7.99B
$1.48M 0.47%
120,000
HEPA
30
DELISTED
Hepion Pharmaceuticals
HEPA
$1.39M 0.44%
+4
New +$1.99M
XXII
31
22nd Century Group
XXII
$2.23M
0
CBMXW
32
DELISTED
CombiMatrix Corporation Warrant
CBMXW
$584K 0.18%
109,075
-5,663
-5% -$7.48K
GCVRZ
33
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$570K 0.18%
1,500,000
+263,787
+21% +$108K
ALCO icon
34
Alico
ALCO
$300M
$527K 0.17%
+16,828
New +$506K
NXTDW
35
DELISTED
Nxt-ID, Inc.
NXTDW
$505K 0.16%
269,900
AIM
36
AIM ImmunoTech
AIM
$7.87M
$462K 0.15%
+210
New +$519K
TOON icon
37
Kartoon Studios
TOON
$39.8M
$449K 0.14%
13,117
-112
-0.8% -$4.61K
ORN icon
38
Orion Group Holdings
ORN
$375M
$344K 0.11%
+46,000
New +$344K
ECYT
39
DELISTED
Endocyte, Inc. Common Stock
ECYT
$287K 0.09%
+191,300
New +$411K
XTIA icon
40
XTI Aerospace
XTIA
$51.9M
0
UNXL
41
PUT
DELISTED
Uni-Pixel, Inc.
UNXL
$249K 0.08%
+650,600
New +$346K
LGMK
42
DELISTED
LogicMark
LGMK
$147K 0.05%
+16
New +$132K
NOVN
43
DELISTED
Novan, Inc. Common Stock
NOVN
$121K 0.04%
3,000
IMNP
44
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$110K 0.03%
+41,935
New +$113K
IMUC.WS
45
DELISTED
ImmunoCellular Therapeutics Ltd.
IMUC.WS
$100K 0.03%
117,188
NSPR icon
46
InspireMD
NSPR
$39.8M
$42K 0.01%
2
AFMD
47
DELISTED
Affimed
AFMD
-14,050
Closed -$323K
ANY icon
48
Sphere 3D
ANY
$19.2M
-91
Closed -$275K
AUPH icon
49
Aurinia Pharmaceuticals
AUPH
$2.17B
-29,900
Closed -$250K
CVM icon
50
CEL-SCI Corp
CVM
$27.4M
-997
Closed -$64K

Similar funds

Anson Funds Management's Q2 2017 Portfolio in Review

As of Q2 2017, Anson Funds Management held 66 positions worth $316M, up 31% from $241M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Anson Funds Management withdrew a net $37.2M in Q2 2017, closing 20 positions and reducing 8 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $18.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 25% a quarter earlier, followed by Materials and Consumer Discretionary.

Against the trend, Anson Funds Management opened a new position in Delek US worth $5.12M.

  • Anson Funds Management's largest Q2 2017 buy was Delek US: 193,600 shares worth $5.12M.
  • Anson Funds Management added most to Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares in Q2 2017, an estimated $4.81M increase.
  • Anson Funds Management's biggest Q2 2017 reduction was Bank of America, cutting an estimated $16M.
  • Anson Funds Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2017, selling an estimated $18.4M.
  • Anson Funds Management's ten largest holdings make up 73% of its $316M portfolio in Q2 2017.
  • Anson Funds Management opened 18 new positions and closed 20 in Q2 2017.
  • Anson Funds Management's portfolio value rose 31% quarter-over-quarter to $316M.

Based on Anson Funds Management's 13F filing for Q2 2017, filed 14 Aug 2017.